Granite Investment Partners »

Halozyme Therapeutics shares owned by Granite Investment Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Granite Investment Partners from 13F filings

Historical chart of Granite Investment Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Granite Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Granite Investment Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $25M 439k 57.24
2024-06-30 $39M 753k 52.36
2024-03-31 $33M 812k 40.68
2023-09-30 $33M 856k 38.20
2023-06-30 $27M 758k 36.07
2023-03-31 $27M 715k 38.19
2022-12-31 $51M 903k 56.90
2022-09-30 $36M 920k 39.54
2022-06-30 $41M 934k 44.00
2022-03-31 $37M 924k 39.88
2021-12-31 $38M 935k 40.21
2021-09-30 $36M 890k 40.68
2021-06-30 $42M 919k 45.41
2021-03-31 $38M 916k 41.69
2020-12-31 $40M 944k 42.71
2020-09-30 $35M 1.3M 26.28
2020-06-30 $34M 1.3M 26.81
2020-03-31 $23M 1.3M 17.99
2019-12-31 $23M 1.3M 17.73
2019-09-30 $14M 867k 15.51
2019-06-30 $15M 857k 17.18
2019-03-31 $16M 1.0M 16.10
2018-12-31 $15M 989k 14.63
2018-09-30 $14M 765k 18.17
2018-06-30 $12M 735k 16.87
2018-03-31 $14M 732k 19.59
2017-12-31 $15M 749k 20.26
2017-09-30 $14M 819k 17.37
2017-06-30 $7.2M 566k 12.82